home > drugs a-z list > viread (tenofovir disoproxil fumarate) drug center

Recommended Topic Related To:

Viread

HIV facts

  • The human immunodeficiency virus (HIV) is a type of virus called a retrovirus, which infects humans when it comes in contact with tissues such as those that line the vagina, anal area, mouth, or eyes, or through a break in the skin.
  • HIV infection is generally a slowly progressive disease in which the virus is present throughout the body at all stages of the disease.
  • Three stages of HIV infection have been described.
    1. The initial stage of infection (primary infection), which occurs within weeks of acquiring the virus, and often is characterized by a flu- or mono-like illness that generally resolves within weeks.
    2. The stage of chronic asymptomatic infection (meaning a long duration of infection without symptoms) lasts an average of eight to 10 years.
    3. The stage of symptomatic infection, in which the body's immune (or defense) system has...

Viread

font size

Viread Drug Center

What is Prescribing information?

The FDA package insert formatted in easy-to-find categories for health professionals and clinicians.

Viread Prescribing Information: Indications & Dosage

VIREAD® (tenofovir disoproxil fumarate) Structural Formula Illustration

HIV-1 Infection

VIREAD® is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and pediatric patients 12 years of age and older.

The following points should be considered when initiating therapy with VIREAD for the treatment of HIV-1 infection:

  • VIREAD should not be used in combination with ATRIPLA®, COMPLERA™, or TRUVADA® [See WARNINGS AND PRECAUTIONS].

Chronic Hepatitis B

VIREAD is indicated for the treatment of chronic hepatitis B in adults.

...

Read the complete drug monograph for Viread »

What is Patient information?

Easy-to-read and understand detailed drug information and pill images for the patient or caregiver from Cerner Multum.

Viread Patient Information: Side Effects

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.

Call your doctor at once if you have any of these serious side effects:

  • liver damage - nausea, stomach pain, low fever, loss of appetite, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes);
  • lactic acidosis - muscle pain or weakness, numb or cold feeling in your arms and legs, dizziness, trouble breathing, stomach pain, nausea with vomiting, slow or uneven heart rate, dizzine...

Read the complete patient information for Viread »

What is Consumer information?

A concise overview of the drug for the patient or caregiver from First DataBank.

Viread Consumer Information: Uses

Tenofovir is used with other medications to help control your HIV infection, thereby improving your quality of life. It helps to decrease the amount of HIV in your body so your immune system can work better. It also lowers your risk of getting HIV disease complications (such as new infections, cancer). Tenofovir belongs to a class of drugs known as nucleotide reverse transcriptase inhibitors (NRTIs).

Tenofovir is not a cure for HIV and it does not prevent the spread of HIV to others through sexual contact or blood contamination (such as sharing used needles).

Tenofovir is also used to tr...

Read the complete consumer information for Viread »

What is Viread Consumer Information?

Warnings - Uses - How to Use - Side Effects - Precautions - Drug Interactions and More

Viread - User Reviews

Viread User Reviews

Now you can gain knowledge and insight about a drug treatment with Patient Discussions.

Here is a collection of user reviews for the medication Viread sorted by most helpful. Patient Discussions FAQs

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


WebMD Daily

Get breaking medical news.